An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
IC
IDG Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 8
- Confirmed lead rounds
- 2 6 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $558M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in all activityAnew Labs
$290MFunding
LeadApex Intelligence
Apex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.
UndisclosedAngel
LeadInfiMaker
Makes desktop five-axis CNC machines for engineers and small businesses
UndisclosedSeries A
Role not disclosedMath Magic
AI platform generating 3D models and personalized physical products
UndisclosedSeries A+
Role not disclosedGrace Investment Machine (GIM)
Building agentic AI systems for capital markets
$20MSeries A
Role not disclosedSpot Biosystems
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
$40MSeries B
Role not disclosedAEON
AEON develops blockchain payment and settlement infrastructure that lets AI agents transact with services and merchants.
$8MPre-Seed
Role not disclosedROBOTERA
Builds humanoid robots with fully in-house hardware for logistics and industrial deployment at scale
$200MGrowth
Role not disclosed